US Patent 6866841 - Non-Endocrine Disrupting Cytoprotective UV Radiation Resistant Substance
Abstract
Compositions for enhanced UV-protective agents that increase immuno-responsiveness by providing cytoprotective additives for mammalian skin while also providing avoidance from endocrine disrupting agents are described. A composition comprising:(a) at least one inorganic sun-blocking agent, (b) optionally at least one non-endocrine disrupting sunscreen agent, (c) at least one non-endocrine disrupting emollient with or mixtures thereof and (d) an optional oil component comprising a carrier oil, preferably an essential oil of a naturally occurring substance and a method of making this and other versions of similar compositions is detailed. The compositions areas shown to be capable of protecting skin and mammalian health from the harmful effects of radiation including ultraviolet light or sunlight by inhibiting the loss of skin immunocompetency and eliminating any endocrine disrupting agents normally utilized as sunscreen agents.
Type
Department
Description
Provenance
Subjects
Citation
Permalink
Citation
Grune, Guerry (2005). US Patent 6866841 - Non-Endocrine Disrupting Cytoprotective UV Radiation Resistant Substance. Retrieved from https://hdl.handle.net/10161/28742.
Collections
Scholars@Duke
Guerry Grune
Guerry has authored over 50 publications and technical disclosures, as well as over 100 U.S. and international patents either pending or granted listing him as either sole or joint inventor. In 2004, Guerry began full-time activities as the Principal of ePatentManager.com, and since then has provided full Intellectual Property development for NC State University (in their Tech Transfer Office), additional Fortune 500 companies including Solvay, Praxair (now Linde), and Exponent and was appointed IP director for Cable Components Group, Ennis-Flint (formerly Flint Trading), AG Essence, and others.
In addition, US Patents 8,326,851 and 10,262,028 were granted to Dr. Grune that describe a portion of his teaching methodology on patent valuation.
Material is made available in this collection at the direction of authors according to their understanding of their rights in that material. You may download and use these materials in any manner not prohibited by copyright or other applicable law.